Green Cross Corp

006280

Company Profile

  • Business description

    Green Cross Corp is one of the global leaders in the healthcare sector. The Montreal-based biopharmaceutical company primarily develops intravenous immunoglobulin (IVIG), a key therapeutic solution for the treatment of patients with infectious and immune diseases, and albumin, used as a blood-volumizing agent and in the treatment of burns. Currently, the company has a global presence through its association with various subsidiaries.

  • Contact

    303 Bojeong-Dong
    Giheung-Gu
    YonginGyeonggi449-070
    KOR

    T: +82 312609300

    http://www.greencross.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    2,276

Stocks News & Analysis

stocks

10 of the cheapest global companies with wide moats

These undervalued stocks of high-quality companies could be attractive investments today.
stocks

Bookworm: Buy and hold inspiration from an unlikely source

Ben Graham was the king of flipping deep value stocks. The best investment of his life came from something very different.
stocks

What next for the largest company on the ASX?

After a historic rally in 2024, what lies ahead for this overvalued banking titan?

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,069.5056.200.70%
CAC 408,028.2890.071.13%
DAX 4022,567.14109.27-0.48%
Dow JONES (US)41,488.19674.621.65%
FTSE 1008,632.3389.771.05%
HKSE23,959.98497.332.12%
NASDAQ17,303.01345.44-1.96%
Nikkei 22537,519.24466.141.26%
NZX 50 Index12,244.8321.42-0.17%
S&P 5005,638.94117.422.13%
S&P/ASX 2007,838.1048.400.62%
SSE Composite Index3,419.560.00-0.00%

Market Movers